PHARMACOEPIDEMIOLOGY OF ARTERIALHYPERTENSION IN CHILDREN: SELECTIONOF ANTIHYPERTENSIVE MEDICATIONS
- Authors: Zharkova LP1
-
Affiliations:
- Issue: Vol 5, No 1 (2008)
- Pages: 68-70
- Section: Articles
- URL: https://journals.eco-vector.com/1994-9480/article/view/117961
- ID: 117961
Cite item
Full Text
Abstract
The survey study demonstrated that the most commonly mentioned medications were ACE inhibitors, diuretics, betaadrenergic
blocking agents and combined medications (papazol and adelphane) and revealed that the majority of physicians
are not informed about modern antihypertensives - angiotensin II receptor blockers and calcium channel blockers.
blocking agents and combined medications (papazol and adelphane) and revealed that the majority of physicians
are not informed about modern antihypertensives - angiotensin II receptor blockers and calcium channel blockers.
Keywords
References
- Александров А. А. // РМЖ. - 1997. - № 9. - С. 559- 565.
- Брязгунов И.П. // Вопросы современной педиатрии. - 2003. - Т. 2, № 3. - С. 68-71.
- А. Г. Автандилов, А.А. Александров, О. А.Кисляк и др. // Педиатрия. - 2003. - Прилож. 1. - № 2. - С. 1-31.
- Кисляк О. И., Петрова Е. В., Чиркова Н. Н. // Сердце. - 2006. - Т. 5, № 4 (28). - С. 190-199.
- Леонова М. В., Белоусов Д. Ю. // Качественная клиническая практика. - 2002. - № 3. - С. 47-53.
- Леонтьева И. В. Кардиология детского возраста: Матер. конф. - 2000. Available from: http://www.Cardiosite.ru
- Мазур Н. А. // Medical Market. - 2000. - Т. 72, № 4. - С. 5-8.
- Сравнительная эффективность гипотензивных препаратов разных классов: результаты исследования ALLHAT (Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial) и их критический анализ //Доказательная кардиол. - 2003. - № 1. - С. 22-26.
- European Society of Hypertension-European Society of Cardiology guidelines for the management of arterial hypertension // J. Hypertens. - 2003. -№ 21. - С. 1011- 1053.
- Bonilla-Felix M. A., Yetman R. J., Portman R. J. Epydemiology of hypertension. In: Pediatric Nephrology, Eds: T.M. Barratt, E.D. Avner, W.E. Harmon, 4-th edition. Lippincott Williams & Wilkins, Baltimore. 1999. - Р. 959-986.
- Flynn J. T. // Am J Hypertens. - 2002. -№ 15 (2Pt2). - Р. 305-335.
- Li J. S., Berezny K., Kilaru R., et al. Dose-Response Study of the Efficacy and Safety of Fosinopril in Children with Hypertension: a Randomized, Double-Blind, Placebo- Controlled, Multicenter Clinical Trial. Hypertension. - 2004. - № 44(3). - Р. 289-293.
- National High Blood Pressure Education Program W orking Group on High Blood Pressure in children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents // Pediatrics. - 2004. - № 114 (2 Suppl 4the Report). - Р. 555-576.
- Updates on the 1987 task force report on high blood pressure in children and adolescents: a working group report from national high blood pressure education program // Pediatrics. - 1996. - № 98 (4). - Р. 649-650.
- Wells T., Soffer B., Shaw W., et al. // J Clin Pharmacol. - 2002. - № 42. - Р. 870-880.
Supplementary files
